Article Text

Download PDFPDF

Canine tricuspid valve malformation, a model of human Ebstein anomaly, maps to dog chromosome 9
Free
  1. G Andelfinger1,
  2. K N Wright1,
  3. H S Lee2,
  4. L M Siemens3,
  5. D W Benson1
  1. 1Cardiovascular Genetics, Division of Cardiology, Cincinnati Children’s Hospital, Cincinnati, OH, USA
  2. 2Center for Genome Information, Department of Environmental Health, University of Cincinnati, Cincinnati, OH, USA
  3. 3Sacramento Veterinary Surgical Services, Sacramento, CA, USA
  1. Correspondence to:
 Dr D W Benson, Cardiovascular Genetics, Division of Cardiology TCHRF ML7042, Cincinnati Children’s Hospital, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; 
 woody.benson{at}cchmc.org

Abstract

Background: Ebstein anomaly of the tricuspid valve is a congenital cardiac malformation characterised by downward displacement of the attachment of the septal and posterior leaflets of the tricuspid valve. Canine tricuspid valve malformation (CTVM) is morphologically similar to Ebstein anomaly; familial occurrence of CTVM has been described. Several observations suggest a genetic cause but most cases appear to be sporadic.

Methods: Three purebred Labrador Retriever kindreds enriched for CTVM underwent clinical examination and echocardiography. DNA was extracted from whole blood. Genotyping was carried out using polymorphic repeat markers with an average spacing of 15 cM and polymorphic information content of 0.74.

Results: Pedigree analysis identified CTVM segregating as an autosomal dominant trait with reduced penetrance. Genome wide linkage analysis in one kindred identified a CTVM susceptibility locus on dog chromosome 9 (CFA9) with a maximum multipoint lod score of 3.33. The two additional kindreds showed a conserved disease haplotype.

Conclusions: This study identifies a CTVM susceptibility locus on CFA9 and a founder effect in apparently unrelated Labrador Retriever kindreds. These results provide the basis for a positional candidate cloning effort to identify the CTVM disease gene. Identification of the CTVM gene will permit mutation screening of patients with Ebstein anomaly, which should provide additional insights into the genetic programmes of valve development.

  • congenital heart defects
  • genetics
  • valves
  • animal model of human disease
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.